{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["191(3)"],"submitter":["Mink van der Molen DR"],"pubmed_abstract":["<h4>Purpose</h4>To evaluate perceived access to health care and preferences for health care provision among patients (being) treated for breast cancer during the COVID-19 pandemic.<h4>Methods</h4>Longitudinal study within the prospective, multicenter UMBRELLA cohort of patients (being) treated for breast cancer. All cohort participants enrolled in UMBRELLA between October 2013 and November 2020 were sent a COVID-19-specific survey during the first and second wave of the COVID-19 pandemic, i.e., April 2020 and November 2020, respectively.<h4>Results</h4>In total, 1106 (69.3%) and 822 (50.9%) cohort participants completed the survey in the first and second wave, respectively. The proportion of patients experiencing that their treatment or follow-up care was affected due to COVID-19 decreased"],"journal":["Breast cancer research and treatment"],"pagination":["553-564"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8635319"],"repository":["biostudies-literature"],"pubmed_title":["The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer."],"pmcid":["PMC8635319"],"pubmed_authors":["Ernst MF","van Stam LE","Bargon CA","Young-Afat DA","Sier M","van Dam IE","Batenburg MCT","Schoenmaeckers EJP","Doeksen A","van Dalen T","Bijlsma RM","van der Leij F","Maarse W","Verkooijen HM","Baas IO","Mink van der Molen DR","on behalf of UMBRELLA study group"],"additional_accession":[]},"is_claimable":false,"name":"The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer.","description":"<h4>Purpose</h4>To evaluate perceived access to health care and preferences for health care provision among patients (being) treated for breast cancer during the COVID-19 pandemic.<h4>Methods</h4>Longitudinal study within the prospective, multicenter UMBRELLA cohort of patients (being) treated for breast cancer. All cohort participants enrolled in UMBRELLA between October 2013 and November 2020 were sent a COVID-19-specific survey during the first and second wave of the COVID-19 pandemic, i.e., April 2020 and November 2020, respectively.<h4>Results</h4>In total, 1106 (69.3%) and 822 (50.9%) cohort participants completed the survey in the first and second wave, respectively. The proportion of patients experiencing that their treatment or follow-up care was affected due to COVID-19 decreased","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Feb","modification":"2026-05-09T05:33:11.901Z","creation":"2022-02-11T14:16:51.454Z"},"accession":"S-EPMC8635319","cross_references":{"pubmed":["34853988"],"doi":["10.1007/s10549-021-06458-3"]}}